Pontus K.E. Börjesson

653 total citations
9 papers, 522 citations indexed

About

Pontus K.E. Börjesson is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Pontus K.E. Börjesson has authored 9 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Radiology, Nuclear Medicine and Imaging, 4 papers in Oncology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Pontus K.E. Börjesson's work include Radiopharmaceutical Chemistry and Applications (6 papers), Peptidase Inhibition and Analysis (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Pontus K.E. Börjesson is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (6 papers), Peptidase Inhibition and Analysis (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Pontus K.E. Börjesson collaborates with scholars based in Netherlands, United States and Sweden. Pontus K.E. Börjesson's co-authors include Jan C. Roos, C. René Leemans, Guus A.M.S. van Dongen, Yvonne W. S. Jauw, Ronald Boellaard, Jonas A. Castelijns, Remco de Bree, Remco de Bree, Maria J.W.D. Vosjan and Ernst J. Postema and has published in prestigious journals such as Clinical Cancer Research, Plastic & Reconstructive Surgery and Journal of Nuclear Medicine.

In The Last Decade

Pontus K.E. Börjesson

9 papers receiving 512 citations

Peers

Countries citing papers authored by Pontus K.E. Börjesson

Since Specialization

Citations

This map shows the geographic impact of Pontus K.E. Börjesson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pontus K.E. Börjesson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pontus K.E. Börjesson more than expected).

Fields of papers citing papers by Pontus K.E. Börjesson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pontus K.E. Börjesson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pontus K.E. Börjesson. The network helps show where Pontus K.E. Börjesson may publish in the future.

Co-authorship network of co-authors of Pontus K.E. Börjesson

This figure shows the co-authorship network connecting the top 25 collaborators of Pontus K.E. Börjesson. A scholar is included among the top collaborators of Pontus K.E. Börjesson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pontus K.E. Börjesson. Pontus K.E. Börjesson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Effect of Endoscopic Brow Lift on Contractures and Synkinesis of the Facial Muscles in Patients with a Regenerated Postparalytic Facial Nerve Syndrome 2013 ·Plastic & Reconstructive Surgery ·Gregor Bran, Pontus K.E. Börjesson, Kofi Boahene, Jan Gosepath, Peter J. F. M. Lohuis	15
2	The Lateral Crural Underlay Spring Graft 2013 ·Facial Plastic Surgery ·(unknown), Pontus K.E. Börjesson, Peter J. F. M. Lohuis, Ferdinand C. A. Timmer	2
3	Radiation Dosimetry of ⁸⁹Zr-Labeled Chimeric Monoclonal Antibody U36 as Used for Immuno-PET in Head and Neck Cancer Patients 2009 ·Journal of Nuclear Medicine ·Pontus K.E. Börjesson, Yvonne W. S. Jauw, Remco de Bree, Jan C. Roos, Jonas A. Castelijns, C. René Leemans, Guus A.M.S. van Dongen, Ronald Boellaard	140
4	Performance of Immuno–Positron Emission Tomography with Zirconium-89-Labeled Chimeric Monoclonal Antibody U36 in the Detection of Lymph Node Metastases in Head and Neck Cancer Patients 2006 ·Clinical Cancer Research ·Pontus K.E. Börjesson, Yvonne W. S. Jauw, Ronald Boellaard, Remco de Bree, Emile F.I. Comans, Jan C. Roos, Jonas A. Castelijns, Maria J.W.D. Vosjan, J. Alain Kummer, C. René Leemans, Adriaan A. Lammertsma, Guus A.M.S. van Dongen	182
5	Radioimmunodetection and radioimmunotherapy of head and neck cancer 2004 ·Oral Oncology ·Pontus K.E. Börjesson, Ernst J. Postema, Remco de Bree, Jan C. Roos, C. René Leemans, Kalevi Kairemo, Guus A.M.S. van Dongen	23
6	Phase I therapy study with (186)Re-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with head and neck squamous cell carcinoma. 2003 ·PubMed ·Pontus K.E. Börjesson, Ernst J. Postema, Jan C. Roos, David R. Colnot, Henri A. M. Marres, (unknown), G. Stehle, Remco de Bree, Gordon B. Snow, Wim J.G. Oyen, Guus A.M.S. van Dongen	93
7	Dosimetric analysis of radioimmunotherapy with 186Re-labeled bivatuzumab in patients with head and neck cancer. 2003 ·PubMed ·Ernst J. Postema, Pontus K.E. Börjesson, W C Buijs, Jan C. Roos, Henri A. M. Marres, Otto C. Boerman, Remco de Bree, Margreet Lang, Gerd Munzert, Guus A.M.S. van Dongen, Wim J.G. Oyen	32
8	Reinfusion of unprocessed, granulocyte colony-stimulating factor-stimulated whole blood allows dose escalation of 186Relabeled chimeric monoclonal antibody U36 radioimmunotherapy in a phase I dose escalation study. 2002 ·PubMed ·David R. Colnot, Gert J. Ossenkoppele, Jan C. Roos, Jasper J. Quak, Remco de Bree, Pontus K.E. Börjesson, Peter C. Huijgens, Gordon B. Snow, Guus A.M.S. van Dongen	25
9	The rat cochlea in the absence of circulating adrenal hormones: an electrophysiological and morphological study 2000 ·Hearing Research ·Peter J. F. M. Lohuis, Pontus K.E. Börjesson, Sjaak F.L. Klis, Guido F. Smoorenburg	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact